The Accreditation Council for Medical Affairs Announces Launch of ACMAi at Fierce Pharma Week 2025

The Accreditation Council for Medical Affairs (ACMA) today announced the global launch of ACMAi Learning Continuum, a first-of-the-kind adaptive, AI-powered learning solution for the pharmaceutical and life sciences industries. The platform is being formally introduced at Fierce Pharma Week 2025, taking place September 9 – 11 at the Pennsylvania Convention Center in Philadelphia.

As the leaders in accreditation, certification, and training for the life sciences, the ACMA brings its proven expertise in evidence-based learning together with advanced proprietary artificial intelligence in the ACMAi Learning Continuum solution.

ACMAi combines tailored learning pathways, accredited curricula, assessment, and simulation-based exercises to support the professional development of medical affairs, market access, and commercial teams.

ACMAi contains 5 key e-learning pillars:

• Certify – Industry-recognized, gold standard certifications for pharma industry enterprise teams.
• Customize – Dynamically built evidence-based adaptive learning modules, personalized training based on an individual’s strengths and areas for improvement.
• Reinforce – Microlearning activities, AI-powered podcasts, and gamification to reinforce and improve knowledge retention and engagement.
• Simulate – AI-powered simulated healthcare provider interactions that allow professionals to compliantly prepare for the real thing.
• Apply – Performance linked to measurable outcomes, driving better stakeholder engagements, richer field insights, and improved goal performance.

“ACMAi represents the next step in our mission to advance industry standards in training and certifying medical science liaisons, medical affairs, reimbursement, and pharmaceutical sales,” said Dr. William Soliman, CEO, ACMA. “By combining ACMA’s leading accredited certifications and expertise in learning, with AI adaptive technology, ACMAi ensures that organizations can train their teams efficiently, consistently, and with impact.”

ACMAi launches at Fierce Pharma Week, with opportunities for attendees to engage directly with the platform and ACMA leadership team at Booth #1021 between September 9 – 11.

About the Accreditation Council for Medical Affairs (ACMA)

The Accreditation Council for Medical Affairs (ACMA) is an accredited, leading global organization dedicated to setting and advancing standards in medical affairs, patient access, and field reimbursement. ACMA partners with more than 900+ life sciences organizations worldwide, with over 500,000 learners in 80+ countries to provide accreditation, certification, and training to pharmaceutical industry and healthcare professionals worldwide.

Media Contact

Robert Laudadio
Director of Strategic Marketing & Partnerships
robert.laudadio@acmainfo.org
cell: 201 819 6145